Evidence map›Paper›PMID 35617956›Full record

ArticleDevelopmental cell2022

A human breast atlas integrating single-cell proteomics and transcriptomics.

G Kenneth Gray, Carman Man-Chung Li, Jennifer M Rosenbluth, Laura M Selfors, Nomeda Girnius, Jia-Ren Lin, Ron C J Schackmann, Walter L Goh, Kaitlin Moore, Hana K Shapiro and 9 more

Abstract read
In one paragraph

Article in Developmental cell, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 98 papers.

0numbers the graph read from it
0cells of the map it votes in
98citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

98 citing papers in PubMed.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Review
  12. Review
  13. Article
  14. Article
  15. Article
  16. Rethinking the microenvironment's role in chemical-induced malignancy.Toxicological sciences : an official journal of the Society of Toxicology · 2026
    Review
  17. Article
  18. Article
  19. Article
  20. Article

38 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

19 authors.

G Kenneth GrayDepartment of Cell Biology, Harvard Medical School (HMS), Boston, MA 02115, USA.
Carman Man-Chung LiDepartment of Cell Biology, Harvard Medical School (HMS), Boston, MA 02115, USA.
Jennifer M RosenbluthDepartment of Cell Biology, Harvard Medical School (HMS), Boston, MA 02115, USA; Department of Medical Oncology, Dana-Farber Cancer Institute (DFCI), Boston, MA 02115, USA; Department of Medicine, University of California, San Francisco, San Francisco, CA 94143, USA.
Laura M SelforsDepartment of Cell Biology, Harvard Medical School (HMS), Boston, MA 02115, USA.
Nomeda GirniusDepartment of Cell Biology, Harvard Medical School (HMS), Boston, MA 02115, USA; The Laboratory of Systems Pharmacology (LSP), HMS, Boston, MA 02115, USA.
Jia-Ren LinThe Laboratory of Systems Pharmacology (LSP), HMS, Boston, MA 02115, USA.
Ron C J SchackmannDepartment of Cell Biology, Harvard Medical School (HMS), Boston, MA 02115, USA.
Walter L GohDepartment of Cell Biology, Harvard Medical School (HMS), Boston, MA 02115, USA.
Kaitlin MooreDepartment of Cell Biology, Harvard Medical School (HMS), Boston, MA 02115, USA.
Hana K ShapiroDepartment of Cell Biology, Harvard Medical School (HMS), Boston, MA 02115, USA.
Shaolin MeiThe Laboratory of Systems Pharmacology (LSP), HMS, Boston, MA 02115, USA.
Kurt D'AndreaDepartment of Medicine, Division of Translation Medicine and Human Genetics, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA 19104, USA.
Katherine L NathansonDepartment of Medicine, Division of Translation Medicine and Human Genetics, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA 19104, USA.
Peter K SorgerThe Laboratory of Systems Pharmacology (LSP), HMS, Boston, MA 02115, USA.
Sandro SantagataThe Laboratory of Systems Pharmacology (LSP), HMS, Boston, MA 02115, USA; Department of Pathology, Brigham and Women's Hospital (BWH), Boston, MA 02115, USA.
Aviv RegevBroad Institute of MIT and Harvard, Cambridge, MA 02142, USA.
Judy E GarberDepartment of Medical Oncology, Dana-Farber Cancer Institute (DFCI), Boston, MA 02115, USA.
Deborah A DillonDepartment of Pathology, Brigham and Women's Hospital (BWH), Boston, MA 02115, USA.
Joan S BruggeDepartment of Cell Biology, Harvard Medical School (HMS), Boston, MA 02115, USA. Electronic address: joan_brugge@hms.harvard.edu.

Funding

Tissue and Pathology CoreP50CA168504 · NCI · DANA-FARBER CANCER INST · PI MYLES A BROWN · 2013 to 2026
$30.1M
Systems Pharmacology of Therapeutic and Adverse Responses to ImmuneCheckpoint and Small Molecule DrugsU54CA225088 · NCI · HARVARD MEDICAL SCHOOL · PI HAIGIS, MARCIA · 2018 to 2022
$10.8M
Tracking the evolution of breast cancer through single cell analyses of premalignant breast tissues from women at high risk for cancer developmentR35CA242428 · NCI · HARVARD MEDICAL SCHOOL · PI BRUGGE, JOAN SIEFERT · 2019 to 2025
$7.1M
Effects of Brca1 Heterozygosity on Mammary Gland BiologyF31CA228200 · NCI · HARVARD MEDICAL SCHOOL · PI GRAY, GARY KENNETH · 2018 to 2020
$103k
NCI NIH HHS F31 CA228200NCI NIH HHS P50 CA168504NCI NIH HHS R35 CA242428NCI NIH HHS U54 CA225088
6 · The paper itself

Abstract

The breast is a dynamic organ whose response to physiological and pathophysiological conditions alters its disease susceptibility, yet the specific effects of these clinical variables on cell state remain poorly annotated. We present a unified, high-resolution breast atlas by integrating single-cell RNA-seq, mass cytometry, and cyclic immunofluorescence, encompassing a myriad of states. We define cell subtypes within the alveolar, hormone-sensing, and basal epithelial lineages, delineating associations of several subtypes with cancer risk factors, including age, parity, and BRCA2 germline mutation. Of particular interest is a subset of alveolar cells termed basal-luminal (BL) cells, which exhibit poor transcriptional lineage fidelity, accumulate with age, and carry a gene signature associated with basal-like breast cancer. We further utilize a medium-depletion approach to identify molecular factors regulating cell-subtype proportion in organoids. Together, these data are a rich resource to elucidate diverse mammary cell states.

Indexed as

Breast NeoplasmsTranscriptomeAnimalsBreastFemaleHumansMammary Glands, AnimalPregnancyProteomicsagingBRCA1BRCA2breast cancercell state plasticityCyTOF mass cytometrymammary biologymulti-omic single-cell atlasmultiplexed tissue stainingorganoidsscRNA-Seq

Identifiers

PMID35617956
PMCPMC9202341

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.